Clinical Trials Logo

Placenta Accreta clinical trials

View clinical trials related to Placenta Accreta.

Filter by:

NCT ID: NCT05871645 Completed - Placenta Accreta Clinical Trials

Placenta Accreta Spectrum Management: Uterine Preservation Using JSICA Technique - Retrospective Cross-Sectional Study

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

The goal of this study is to present the Jakarta Surgical Uterine Conservation (JSICA) technique and its perioperative outcomes in Placenta Accreta Spectrum patients. Participants are all patients undergoing standard hysterectomy or the Jakarta Surgical Uterine Conservation (JSICA) technique. Researchers will compare both groups to see if there are any differences in the perioperative outcomes.

NCT ID: NCT05813743 Completed - Placenta Accreta Clinical Trials

Detection of Urinary Bladder Wall Involvement in Abnormally Invasive Placenta (AIP) by 3D Ultrasonography

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

In the last three decades , the raise in cesarean delivery rates has led to a massive increase in the incidence of the abnormally invasive placenta .Complete separation of the abnormally invasive placenta is very difficult and usually fails and this may leads to life threatening hemorrhage and other morbidities e.g injury of the urinary tract. Antenatal diagnosis of the extent of the myometrial involvement may help in the anticipation and the planning of management eg: to proceed a conservative management or cesarean hysterectomy in case of extensive myometrial involvement . Three dimensional (3D) power Doppler ultrasound now represents a turning point for diagnosis the abnormal placentation .

NCT ID: NCT05806528 Not yet recruiting - Placenta Accreta Clinical Trials

Role of Placental Invasion Index in Decision Making of Placenta Accreta

Start date: April 1, 2023
Phase:
Study type: Observational

This study will be conducted on women who have a diagnosis of placenta previ and using ultrasound to make the placenta invasion index and compare the accuracy of the diagnosis during the caesarean section whether it is accreta or not with determining the site and depth of invasion

NCT ID: NCT05752513 Recruiting - Clinical trials for Placenta Accreta Spectrum

Early vs Late Bladder Dissection During CS Hysterectomy in Patients With PAS With Bladder Invasion

Start date: February 23, 2023
Phase: N/A
Study type: Interventional

Thirty-six singleton pregnant women with PAS and bladder invasion; total anterior or anterolateral invasion, who were scheduled for cesarean hysterectomy were randomly assigned into two equal groups - Group 1: included 18 pregnant women scheduled for classical cesarean hysterectomy for placenta accreta with or without ligation of anterior division of internal iliac artery before cesarean section. - Group 2: included 18 pregnant women scheduled for bladder last cesarean hysterectomy with or without ligation of anterior division of internal iliac artery.

NCT ID: NCT05636865 Active, not recruiting - Placenta Accreta Clinical Trials

Descriptive Study of the Incidence and Outcome of PAS in Two Large Referral Hospitals in Egypt

Start date: July 30, 2022
Phase:
Study type: Observational

placenta accreta spectrum incidence and outcome

NCT ID: NCT05542043 Completed - Clinical trials for Postpartum Hemorrhage (PPH)

Risk Factors for Postpartum Hemorrhage in Patients With Histologically Verified Placenta Accreta

Start date: July 1, 2020
Phase:
Study type: Observational

This retrospective, monocentric study aims to examine risk factors for postpartum hemorrhage in women with histologically verified placenta accreta. Women with histologically verified placenta accreta are divided into two groups: women with normal blood loss (BV < 500 ml) versus women with increased blood loss (BV ≥ 500 ml). The clinical data of pregnant women with histologically verified placental disorders, who gave birth in the Women's Clinic University Hospital Basel (USB) between 1986 and 2019, are compared with each other.

NCT ID: NCT05513092 Not yet recruiting - Clinical trials for Placenta Accreta, Third Trimester

Placenta Accreta Index Score in Placenta Accreta Spectrum

Start date: August 2022
Phase:
Study type: Observational

role of placenta accreta index score in prediction of conservative surgery for placenta placenta accreta spectrum

NCT ID: NCT05510076 Recruiting - Clinical trials for Placenta Accreta Spectrum

Evaluation of Different Surgical Approaches Used for Conservative Management of Placenta Accreta Spectrum in Sohag University Hospital

Start date: August 1, 2022
Phase:
Study type: Observational

The objective of this study is to evaluate different intra-operative procedures to control bleeding in cases of PAS disorders aiming to determine the best procedure regarding maternal morbidity and mortality post-operatively, and to evaluate the long-term effects of conservative management of PAS disorders.

NCT ID: NCT05500404 Completed - Clinical trials for Placenta Accreta Spectrum

Diagnostic Accuracy of Placental Thickness in Lower Uterine Segment Measured By Ultrasound in Prediction of Placenta Accreta Spectrum in Patients With Placenta Previa. A Diagnostic Test Accuracy Study

Start date: December 1, 2021
Phase:
Study type: Observational

Current prenatal diagnosis of placenta accrete spectrum disorders relies on subjective individual interpretations of visual sonographic findings on grayscale and color Doppler imaging. When blinded to clinical data, there is significant interobserver variability in the diagnosis of invasive placentation. This study will evaluate placental thickness among pregnant women with placenta previa and determine if increased placenta thickness correlates with the risk for placenta accreta spectrum (PAS) disorders.

NCT ID: NCT05481606 Not yet recruiting - Hysterectomy Clinical Trials

Cesarean Scar Pregnancy and Clinical Outcomes

Start date: August 1, 2022
Phase:
Study type: Observational [Patient Registry]

This study is a prospective cohort study, led by Prof. Zhao Yangyu, from the Department of Gynecology & Obstetrics, Peking University Third Hospital.